Efficacy and cost implications of the new cephalosporins. Vancouver, British Columbia, Canada, August 21-22, 1987. Proceedings.
D015313:Cefotetan; D002440:Cefoxitin / Q000627:therapeutic use*; D002513:Cephamycins / Q000627:therapeutic use*; D003365:Costs and Cost Analysis; D006801:Humans
D002513:Cephamycins; D015313:Cefotetan; D002440:Cefoxitin